Bio-Rad Laboratories, Inc.
markets and distributes a broad range of products for the life science research and clinical diagnostic markets. The company is based in Hercules
, United States
and serves research and industry customers worldwide through its global network of operations. The company employs over 6,300 people globally and had revenues of nearly $1.5 billion in 2007. The company has two main operating groups: Life Science and Clinical Diagnostics. Bio-Rad was founded in 1957 by David & Alice Schwartz.
Life Science Research
Bio-Rad's Life Science Research Group is best known for its pioneering work in electrophoresis
for over 50 years. Other key areas of strength are DNA amplification
, imaging, gene transfer
technology, nucleic acid and protein quantitation, protein expression, blotting
, multiplexing assays, software and the Biotechnology Explorer Program. Since 1999 tests for HIV-1 and HIV-2; Hepatitis A, B and C; syphilis and CMV and Immunohematology are other key areas. Bio-Rad is also notable for developing a test for BSE (bovine spongiform encephalopathy
, or mad cow disease) in 2000. Bio-Rad became the first company to supply the tests to Europe and Japan in 2001.
The journal Nature reports that Bio-Rad's and other manufacturers' high prices of supplies drain cash from poorer nations' labs However, this may be an unavoidable consequence of normal supply and demand.
Bio-Rad has an office in Hemel Hempstead, England. This office used to have a large manufacturing division (cellscience), which was closed down and sold to Carl Zeiss in 2004 Since this time, the Hemel Hempstead offices have moved to a smaller building.